Ines Hernandez-Rodriguez

Ines Hernandez-Rodriguez


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
BSBEATRIZ CADENAS SEVILLA
BEATRIZ CADENAS SEVILLA
JFJosep Fita-Torró
Josep Fita-Torró
MBMar Bermúdez-Cortés
Mar Bermúdez-Cortés
IHInes Hernandez-Rodriguez
Ines Hernandez-Rodriguez
JFJosé L Fuster
José L Fuster
MSMayka Sanchez
Mayka Sanchez
Ferritin is a multimeric protein composed of light (L-ferritin) and heavy (H-ferritin) subunits that binds and stores iron inside the cell. A variety of mutations have been reported in the L-ferritin subunit gene (FTL gene) that cause the following five diseases: (1) hereditary hyperferritinemia with cataract syndrome (HHCS), (2) neuroferritinopathy, a subtype of neurodegeneration with brain iron accumulation (NBIA), (3) benign hyperferritinemia, (4) L-ferritin deficiency with autosomal dominant inheritance, and (5) L-ferritin deficiency with autosomal recessive inheritance. Defects in the FTL gene lead to abnormally high levels of serum ferritin (hyperferritinemia) in HHCS and benign hyperferritinemia, while low levels (hypoferritinemia) are present in neuroferritinopathy and in autosomal dominant and recessive L-ferritin deficiency. Iron disturbances as well as neuromuscular and cognitive deficits are present in some, but not all, of these diseases. Here, we identified two novel FTL variants that cause dominant L-ferritin deficiency and HHCS (c.375+2T > A and 36_42delCAACAGT, respectively), and one previously reported variant (Met1Val) that causes dominant L-ferritin deficiency. Globally, genetic changes in the FTL gene are responsible for multiple phenotypes and an accurate diagnosis is useful for appropriate treatment. To help in this goal, we included a diagnostic algorithm for the detection of diseases caused by defects in FTL gene.

Verified
Journal Article
Open access
PDF file
FCFerran Celma
Ferran Celma
GVGonzalo Hernandez Viedma
Gonzalo Hernandez Viedma
XFXènia Ferrer-Cortès
Xènia Ferrer-Cortès
IHInes Hernandez-Rodriguez
Ines Hernandez-Rodriguez
BNBegoña Navarro-Almenzar
Begoña Navarro-Almenzar
MSMayka Sanchez
Mayka Sanchez
Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare disease characterized by high serum ferritin levels, congenital bilateral cataracts, and the absence of tissue iron overload. This disorder is produced by mutations in the iron responsive element (IRE) located in the 5′ untranslated regions (UTR) of the light ferritin (FTL) gene. A canonical IRE is a mRNA structure that interacts with the iron regulatory proteins (IRP1 and IRP2) to post-transcriptionally regulate the expression of proteins related to iron metabolism. Ferritin L and H are the proteins responsible for iron storage and intracellular distribution. Mutations in the FTL IRE abrogate the interaction of FTL mRNA with the IRPs, and de-repress the expression of FTL protein. Subsequently, there is an overproduction of ferritin that accumulates in serum (hyperferritinemia) and excess ferritin precipitates in the lens, producing cataracts. To illustrate this disease, we report two new families affected with hereditary hyperferritinemia-cataract syndrome with previous known mutations. In the diagnosis of congenital bilateral cataracts, HHCS should be taken into consideration and, therefore, it is important to test serum ferritin levels in patients with cataracts.

16 February 2023 in Thalassemia Reports
Verified
Journal Article
Open access
PDF file
EKElena Krishnevskaya
Elena Krishnevskaya
MMMarta Molero
Marta Molero
ÁAÁgueda Ancochea
Águeda Ancochea
IHInes Hernandez-Rodriguez
Ines Hernandez-Rodriguez
JCJoan-Lluis Vives Corrons
Joan-Lluis Vives Corrons
Next-generation ektacytometry provided by the osmoscan module of the Laser Optical Rotational Red Cell Analyser (LoRRca) MaxSis is, so far, one of the best complementary diagnostic tools for congenital rare anaemias due to red blood cell defects. Osmotic gradient ektacytometry (OGE) is currently considered the gold standard for the diagnosis of red cell membrane disorders, especially hereditary spherocytosis (HS). Impairment of red cell deformability, leading to a decrease in red cell survival rate, is the common trait of hereditary haemolytic anaemias; in general, it is the consequence of an abnormal cell shape, increased rigidity or dehydration. Up to now, the next-generation ektacytometry has been mainly used for the differential diagnosis of red blood cell membranopathies, but experience with structural hemoglobinopathies and thalassemia is still scarce. However, recently, many new forms of therapy are being developed for the treatment of hemoglobinopathies, particularly sickle-cell disease and β-thalassemia; clinical interest in ektacytometry is increasing and should be further explored. Here, we have evaluated the OGE profiles provided by the osmoscan module of the LoRRca ektacytometer in 96 patients with different hemoglobinopathies, both structural and thalassemia, with the aim of analysing their usefulness for the early diagnosis of these disorders either individually or in co-inheritance with other hereditary RBC defects. In addition, this study aims to improve our knowledge of the contribution of red cell deformability, osmotic fragility and intracellular viscosity to the physiopathology of haemolysis, especially when these disorders are a cause of rare anaemia. From this study, we conclude that the osmoscan profile provides complementary information on red cell deformability and hydration homeostasis that may contribute to the better understanding of the physiopathology of decreased red cell survival and hemolysis which is present in some patients.

13 December 2021 in Genes
Verified
Journal Article
Open access
PDF file
GVGonzalo Hernandez Viedma
Gonzalo Hernandez Viedma
XFXenia Ferrer-Cortès
Xenia Ferrer-Cortès
VVVeronica Venturi
Veronica Venturi
MMMelina Musri
Melina Musri
MPMartin Floor Pilquil
Martin Floor Pilquil
MSMayka Sanchez
Mayka Sanchez
Hereditary hemochromatosis (HH) is an iron metabolism disease clinically characterized by excessive iron deposition in parenchymal organs such as liver, heart, pancreas, and joints. It is caused by mutations in at least five different genes. HFE hemochromatosis is the most common type of hemochromatosis, while non-HFE related hemochromatosis are rare cases. Here, we describe six new patients of non-HFE related HH from five different families. Two families (Family 1 and 2) have novel nonsense mutations in the HFE2 gene have novel nonsense mutations (p.Arg63Ter and Asp36ThrfsTer96). Three families have mutations in the TFR2 gene, one case has one previously unreported mutation (Family A—p.Asp680Tyr) and two cases have known pathogenic mutations (Family B and D—p.Trp781Ter and p.Gln672Ter respectively). Clinical, biochemical, and genetic data are discussed in all these cases. These rare cases of non-HFE related hereditary hemochromatosis highlight the importance of an earlier molecular diagnosis in a specialized center to prevent serious clinical complications.

1 March 2022 in Medicina Clinica
Verified
Journal Article
Closed access
CECarlos Esteban
Carlos Esteban
IHInes Hernandez-Rodriguez
Ines Hernandez-Rodriguez

10 August 2023 in Medicina Clinica
Verified
Journal Article
Closed access
MCMarta Canelo-Vilaseca
Marta Canelo-Vilaseca
IHInes Hernandez-Rodriguez
Ines Hernandez-Rodriguez
JNJosé-Tomás Navarro
José-Tomás Navarro